Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

NCT00794235 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT00794235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine
Lead sponsor
University of Zurich
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
January 31, 2010
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma stage iii or iv, no prior chemotherapy